Mungmunpuntipantip R, Wiwanitkit V. Safety Margin for Plasma Hyperviscosity in Cardiovascular Disease Patients after COVID-19 Vaccination for Thrombosis Prevention. Arquivos Brasileiros de Cardiologia 2021;117(6):1217-8.
Mungmunpuntipantip, Rujittika; Wiwanitkit, Viroj. Safety Margin for Plasma Hyperviscosity in Cardiovascular Disease Patients after COVID-19 Vaccination for Thrombosis Prevention. Arquivos Brasileiros de Cardiologia, v. 117, n. 6, p. 1217-1218, Dec. 2021.
Mungmunpuntipantip, R., & Wiwanitkit, V. (2021). Safety Margin for Plasma Hyperviscosity in Cardiovascular Disease Patients after COVID-19 Vaccination for Thrombosis Prevention. Arquivos Brasileiros de Cardiologia, 117(6), 1217-1218.
Mungmunpuntipantip, Rujittika and Wiwanitkit, Viroj. Safety Margin for Plasma Hyperviscosity in Cardiovascular Disease Patients after COVID-19 Vaccination for Thrombosis Prevention. Arquivos Brasileiros de Cardiologia [online]. 2021, vol. 117, n. 6, [cited 2026-10-14], pp. 1217-1218. Available from: <https://journals.cardiol.br/en/article/safety-margin-for-plasma-hyperviscosity-in-cardiovascular-disease-patients-after-covid-19-vaccination-for-thrombosis-prevention/>. ISSN 0066-782X